Paige AI

The company was started by David Klimstra, Norman Selby, Peter Schuffler, and Thomas Fuchs in 2018 and to date has raised $220 million in funding. The company makes software to support pathologists in the detection of abnormalities in biopsy images. Key differentiating claims of the company include ...

This research is archived and therefore no longer available. For further assistance please contact your Customer Success Manager or email Thank you!

Related Research

Clear Labs

Company Snapshot | January 14, 2021

The company was started by Dr. Sasan Amini (Chief Executive Officer) and Mahni Ghorashi (former Chief Commercial Officer), both with experience in genomics testing. To date, the company has raised about $62 million, most recently from an $18 million round in May 2020. Among its investors, we ... To read more, click here.


Company Snapshot | June 28, 2021

The company was started by CEO Chris Toumazou and CSO Maria Karvela in 2015; the company has raised an undisclosed amount of funding to date and had its most recent funding round in 2021. The company is a developer of a direct‑to‑consumer nutrigenetics service that gathers insights on users' genetic... To read more, click here.


Company Snapshot | August 04, 2021

The company was started by CEO Alexander Bisignano and Santiago Munne in 2016; it has raised $18 million in funding to date, including $8 million from its most recent round in 2020. The company develops GeneCompass, a consumer genetic testing kit for preventative and holistic care, based on next‑... To read more, click here.